The TWH1500, using water-filtered infrared A with a high and most compliant energy input to deeper tissue layers (see wIRA insert hyperlink), is the first oncological local hyperthermia device that enables a contact-free supply of energy.
- That allows for
continous real-time thermographic control
with automatic switch on and off control functions making possible a optimal and safe energy input, achieving an effective heating depth of (>40°C) of at least 15mm (>40°C) resp. 20mm (>39.5°C) if max. skin temperature is set at 42- 43°C.
- Thereby, the incidents of
thermal skin damage (TSD) ≥ grade 2 has been reduced to 0 %
(median in published microwave hyperthermia studies is approx. 25%). Additionally, the physiological reactions in the treatment area can be observed real-time and analyzed even afterwards.
- The treatment is
most agreeable for the patient.
The patient does not suffer from any body fixation or painful applicator contact, e.g. with ulcerated lesions.
By a twin-applicator system, TWH1500 – independantly of heterogenous body contours – easily covers large treatment areas for effective hyperthermia of large-sized chest wall recurrence, especially in lymphangiosis carcinomatosa.
Thermography-controlled wIRA superficial hyperthermia is an approved method in the “Quality assurance guidelines for superficial hyperthermia clinical trials”, issued by ESHO (European Society for Hyperthermic Oncology) and published in Int J Hyperthermia. 2017 and Strahlenther Onkol 2017.